Skip to main content
SpringerLink
Log in

Neue Immuntherapien zugelassen

Non-Hodgkin- und Hodgkin-Lymphome: Behandlungsstandards im Wandel

New treatment options for patients with Non-Hodgkin and Hodgkin lymphoma: changing treatment standards and improvements in prognosis

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© V. Bücklein

Abb. 2

© V. Bücklein

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik III, Marchioninistr. 15, 81377, München, Deutschland

    Veit Bücklein LMU Klinikum

Authors
  1. Veit Bücklein LMU Klinikum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Veit Bücklein LMU Klinikum.

Ethics declarations

V. Bücklein erhält Forschungsförderung von Kite/Gilead und Roche. Er hat für Kite/Gilead Beratertätigkeiten übernommen und war als Sprecher bei Gilead- und Novartis-Veranstaltungen eingeladen.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bücklein, V. Non-Hodgkin- und Hodgkin-Lymphome: Behandlungsstandards im Wandel. MMW - Fortschritte der Medizin 165, 48–51 (2023). https://doi.org/10.1007/s15006-022-2185-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-022-2185-0

Keywords:

Search

Navigation